Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.690
 Why?
Cancer Vaccines
13
2022
78
2.520
 Why?
Peptides
17
2022
223
2.450
 Why?
Carbohydrates
14
2009
41
2.280
 Why?
Molecular Mimicry
13
2007
38
1.930
 Why?
Breast Neoplasms
12
2024
1212
1.650
 Why?
Neoplasms
9
2022
1325
1.410
 Why?
Immunotherapy
6
2022
244
1.060
 Why?
Epitopes, T-Lymphocyte
6
2009
26
0.860
 Why?
HIV Envelope Protein gp120
4
2009
13
0.800
 Why?
Antibodies, Neoplasm
2
2017
28
0.780
 Why?
Lung Neoplasms
4
2014
636
0.780
 Why?
HIV-1
4
2009
59
0.780
 Why?
Mice, Inbred BALB C
16
2011
312
0.760
 Why?
Antigens
4
2003
41
0.740
 Why?
Animals
31
2023
13505
0.640
 Why?
Epithelial-Mesenchymal Transition
2
2020
57
0.620
 Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.600
 Why?
Gene Expression Regulation, Neoplastic
5
2020
857
0.590
 Why?
Vaccines, DNA
6
2006
11
0.590
 Why?
Immunologic Surveillance
2
2009
10
0.590
 Why?
HIV Antigens
3
2006
9
0.560
 Why?
Epitopes
3
2009
65
0.550
 Why?
Cell Transformation, Neoplastic
1
2018
184
0.540
 Why?
Antineoplastic Agents
3
2017
1222
0.510
 Why?
Immunity, Innate
3
2018
117
0.510
 Why?
Neoplasm Proteins
1
2018
334
0.490
 Why?
Molecular Targeted Therapy
1
2017
133
0.490
 Why?
Mice
20
2011
5949
0.490
 Why?
Cell Hypoxia
1
2015
83
0.460
 Why?
Biomimetic Materials
1
2014
11
0.460
 Why?
Estrogen Receptor alpha
1
2015
85
0.460
 Why?
Epigenesis, Genetic
1
2018
406
0.450
 Why?
Vaccines
4
2002
51
0.430
 Why?
T-Lymphocytes
7
2010
340
0.420
 Why?
Cross Reactions
8
2006
41
0.420
 Why?
Oligosaccharides
4
2007
34
0.420
 Why?
Amino Acid Sequence
9
2006
578
0.420
 Why?
Molecular Sequence Data
9
2006
778
0.410
 Why?
Sarcoma, Experimental
2
2004
14
0.410
 Why?
Antigens, Neoplasm
5
2007
147
0.410
 Why?
Polysaccharides
2
2011
57
0.400
 Why?
Humans
35
2024
52483
0.400
 Why?
AIDS Vaccines
3
2009
11
0.390
 Why?
Plant Lectins
2
2010
8
0.380
 Why?
Isoflavones
1
2023
88
0.380
 Why?
Sulfotransferases
3
2020
38
0.370
 Why?
Chondroitin Sulfates
2
2011
15
0.360
 Why?
P-Selectin
2
2011
30
0.360
 Why?
Soybean Proteins
1
2023
162
0.360
 Why?
CD8-Positive T-Lymphocytes
3
2007
132
0.350
 Why?
Autoantigens
1
2011
53
0.350
 Why?
Fructose
1
2010
22
0.350
 Why?
Carbon
1
2010
55
0.340
 Why?
Adaptive Immunity
1
2010
34
0.340
 Why?
CD4-Positive T-Lymphocytes
3
2006
164
0.320
 Why?
Vaccines, Subunit
3
2006
15
0.320
 Why?
Obesity
2
2023
1162
0.320
 Why?
Carcinoma, Ductal
1
2008
7
0.300
 Why?
Drug Delivery Systems
1
2010
154
0.300
 Why?
Proteoglycans
3
2023
87
0.290
 Why?
Mammary Neoplasms, Experimental
2
2005
122
0.290
 Why?
Interferon-gamma
4
2018
180
0.280
 Why?
Carcinoma in Situ
1
2008
72
0.280
 Why?
Cell Line, Tumor
6
2011
1470
0.280
 Why?
Dendritic Cells
3
2005
136
0.270
 Why?
T-Lymphocytes, Cytotoxic
5
2009
66
0.270
 Why?
Female
18
2024
28171
0.260
 Why?
Concanavalin A
2
2005
11
0.250
 Why?
Sarcoma
1
2006
72
0.240
 Why?
Mammary Neoplasms, Animal
1
2005
35
0.240
 Why?
HIV Infections
1
2009
389
0.240
 Why?
Ligands
5
2011
206
0.230
 Why?
MCF-7 Cells
4
2020
64
0.230
 Why?
Neoplasm Metastasis
5
2015
243
0.230
 Why?
Magnetic Resonance Spectroscopy
1
2005
253
0.230
 Why?
Acetylglucosamine
1
2004
7
0.220
 Why?
Histocompatibility Antigens Class I
1
2004
48
0.220
 Why?
Combined Modality Therapy
2
2017
639
0.210
 Why?
Melanoma
1
2007
288
0.210
 Why?
Immunoglobulin G
2
2003
195
0.210
 Why?
Immunotherapy, Active
1
2003
4
0.210
 Why?
Peptide Fragments
1
2004
203
0.210
 Why?
Peptide Library
4
2005
16
0.200
 Why?
Glycosylation
3
2010
106
0.200
 Why?
Autoantibodies
2
2018
121
0.200
 Why?
Cell Proliferation
4
2020
1023
0.200
 Why?
Antigens, Viral
1
2002
43
0.190
 Why?
Apoptosis
2
2020
1119
0.190
 Why?
Antibodies, Monoclonal
5
2023
481
0.190
 Why?
Biochemistry
1
2001
6
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
235
0.180
 Why?
Liver Neoplasms
1
2005
333
0.180
 Why?
Cell Adhesion
3
2006
163
0.170
 Why?
Carbamates
1
2020
16
0.170
 Why?
CHO Cells
3
2006
125
0.170
 Why?
Cricetinae
3
2006
194
0.170
 Why?
Adjuvants, Immunologic
2
2014
52
0.170
 Why?
Colchicine
1
2020
24
0.170
 Why?
Antineoplastic Agents, Phytogenic
1
2020
71
0.160
 Why?
Carcinoma, Ductal, Breast
1
2020
90
0.160
 Why?
Neoplastic Stem Cells
1
2020
99
0.160
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
91
0.150
 Why?
Anthroposophy
1
2018
1
0.150
 Why?
Tumor Microenvironment
2
2024
256
0.150
 Why?
Tumor Cells, Cultured
3
2015
460
0.150
 Why?
Antibody Formation
3
2003
51
0.150
 Why?
Cell Division
3
2006
291
0.150
 Why?
Gene-Environment Interaction
1
2018
40
0.150
 Why?
Immunization
3
2004
69
0.140
 Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.140
 Why?
Immune Tolerance
2
2009
91
0.140
 Why?
Plant Extracts
1
2020
194
0.140
 Why?
Flow Cytometry
3
2006
478
0.140
 Why?
Cell Movement
4
2020
268
0.140
 Why?
Spleen
3
2004
172
0.140
 Why?
Homeostasis
1
2018
201
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.130
 Why?
Forecasting
1
2017
154
0.130
 Why?
HIV Antibodies
2
2006
15
0.130
 Why?
Models, Immunological
2
2007
8
0.120
 Why?
Membrane Proteins
2
2023
335
0.120
 Why?
Interleukin-12
2
2006
27
0.120
 Why?
Lectins
2
2006
14
0.120
 Why?
Phenotype
2
2010
789
0.120
 Why?
Coculture Techniques
1
2015
144
0.120
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
59
0.120
 Why?
Drug Therapy
1
2014
44
0.110
 Why?
Transforming Growth Factor beta
1
2015
138
0.110
 Why?
Antibodies
1
2014
159
0.110
 Why?
Adipocytes
1
2015
132
0.110
 Why?
Vaccines, Conjugate
2
2005
9
0.110
 Why?
Nuclear Proteins
1
2015
245
0.110
 Why?
Cell Separation
2
2005
83
0.100
 Why?
Scavenger Receptors, Class E
1
2015
204
0.100
 Why?
Rats, Zucker
1
2023
73
0.100
 Why?
Positron-Emission Tomography
1
2014
301
0.100
 Why?
Cytotoxicity, Immunologic
2
2005
58
0.100
 Why?
Protein Binding
2
2005
667
0.100
 Why?
Immunity, Cellular
2
2003
64
0.100
 Why?
Mutation
1
2018
1347
0.100
 Why?
Mice, Nude
2
2004
265
0.100
 Why?
Lymphocyte Activation
3
2001
172
0.100
 Why?
C-Reactive Protein
1
2023
155
0.090
 Why?
Kinetics
2
2005
626
0.090
 Why?
Injections, Intramuscular
2
2003
56
0.090
 Why?
Interleukin-6
1
2023
278
0.090
 Why?
Binding Sites
2
2003
377
0.090
 Why?
Prognosis
3
2020
2099
0.090
 Why?
Tumor Necrosis Factor-alpha
1
2023
399
0.090
 Why?
Microscopy, Phase-Contrast
1
2010
13
0.090
 Why?
Body Weight
1
2023
523
0.090
 Why?
Lung
1
2014
509
0.090
 Why?
Transfection
3
2007
357
0.090
 Why?
B-Lymphocytes
2
2002
184
0.090
 Why?
DNA Methylation
1
2015
592
0.090
 Why?
Antigens, CD
2
2003
218
0.080
 Why?
Substrate Specificity
1
2010
193
0.080
 Why?
Membrane Glycoproteins
2
2003
244
0.080
 Why?
Actins
1
2010
115
0.080
 Why?
Dose-Response Relationship, Drug
2
2005
1378
0.080
 Why?
Antibodies, Catalytic
1
2009
1
0.080
 Why?
Receptors, CCR5
1
2009
7
0.080
 Why?
Neoplasm Invasiveness
1
2010
278
0.080
 Why?
Cells, Cultured
2
2003
1567
0.080
 Why?
Time Factors
2
2005
2968
0.080
 Why?
Killer Cells, Natural
1
2009
116
0.070
 Why?
Fucosyltransferases
1
2007
5
0.070
 Why?
Glycosaminoglycans
1
2007
19
0.070
 Why?
Male
3
2023
26761
0.070
 Why?
Molecular Biology
1
2007
27
0.070
 Why?
Binding Sites, Antibody
1
2006
15
0.070
 Why?
Rats
1
2023
3220
0.070
 Why?
Amino Acid Motifs
1
2006
57
0.070
 Why?
Heparin
1
2007
88
0.060
 Why?
Cricetulus
1
2006
104
0.060
 Why?
Cell Membrane
1
2007
245
0.060
 Why?
Antineoplastic Agents, Alkylating
1
2006
77
0.060
 Why?
E-Selectin
1
2005
13
0.060
 Why?
Xenograft Model Antitumor Assays
1
2006
220
0.060
 Why?
Cyclophosphamide
1
2006
171
0.060
 Why?
Wheat Germ Agglutinins
1
2005
3
0.060
 Why?
Densitometry
1
2005
13
0.060
 Why?
Mannose
1
2005
16
0.060
 Why?
Hydrocarbons
1
2005
14
0.060
 Why?
Surface Plasmon Resonance
1
2005
23
0.060
 Why?
Methane
1
2005
11
0.060
 Why?
Phosphorylcholine
1
2005
20
0.060
 Why?
Bone Marrow Cells
1
2006
190
0.060
 Why?
Growth Inhibitors
1
2005
26
0.060
 Why?
Biosensing Techniques
1
2005
30
0.060
 Why?
Calcium
1
2007
376
0.060
 Why?
Immunoglobulins
1
2005
76
0.060
 Why?
Glycolysis
1
2005
73
0.060
 Why?
Genetic Variation
1
2006
230
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
405
0.060
 Why?
Antigen Presentation
1
2004
26
0.060
 Why?
Endothelial Cells
1
2006
262
0.060
 Why?
Cytosol
1
2004
80
0.050
 Why?
Bone Neoplasms
1
2006
184
0.050
 Why?
Treatment Outcome
1
2014
5422
0.050
 Why?
Immunoglobulin Constant Regions
1
2003
3
0.050
 Why?
Plasmids
2
2003
163
0.050
 Why?
Recombinant Proteins
1
2005
483
0.050
 Why?
Middle Aged
2
2020
13028
0.050
 Why?
Histocompatibility Antigens Class II
1
2003
36
0.050
 Why?
Antibodies, Viral
1
2003
109
0.050
 Why?
Bacterial Capsules
1
2003
19
0.050
 Why?
DNA, Neoplasm
1
2003
146
0.050
 Why?
Immunoglobulin M
1
2003
60
0.050
 Why?
Th1 Cells
1
2003
55
0.050
 Why?
Carbohydrate Metabolism
1
2002
23
0.050
 Why?
Antibodies, Anti-Idiotypic
1
2002
25
0.050
 Why?
Models, Chemical
1
2002
66
0.050
 Why?
L-Selectin
1
2001
7
0.050
 Why?
Calorimetry
1
2001
6
0.050
 Why?
Carbohydrate Sequence
1
2001
10
0.050
 Why?
Epitope Mapping
1
2001
7
0.050
 Why?
Thermodynamics
1
2001
35
0.050
 Why?
Binding, Competitive
1
2001
90
0.050
 Why?
Mice, Inbred CBA
1
2001
37
0.050
 Why?
Protein Structure, Secondary
1
2001
71
0.050
 Why?
Sequence Homology, Amino Acid
1
2001
140
0.040
 Why?
Gene Expression Profiling
1
2006
1105
0.040
 Why?
Protein Conformation
1
2001
176
0.040
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.040
 Why?
Injections, Intraperitoneal
1
2000
57
0.040
 Why?
Colchicum
1
2020
3
0.040
 Why?
Inhibitory Concentration 50
1
2020
74
0.040
 Why?
Models, Molecular
1
2001
348
0.040
 Why?
Drug Screening Assays, Antitumor
1
2020
136
0.040
 Why?
H-2 Antigens
1
1999
4
0.040
 Why?
Wnt Signaling Pathway
1
2020
94
0.040
 Why?
Receptors, Estrogen
1
2020
131
0.040
 Why?
Child, Preschool
1
2008
4076
0.040
 Why?
Transformation, Genetic
1
1998
17
0.040
 Why?
Glycoside Hydrolases
1
1998
18
0.040
 Why?
Clostridium
1
1998
17
0.040
 Why?
Cell Survival
1
2020
612
0.040
 Why?
Genes, Reporter
1
1998
88
0.040
 Why?
Plants
1
1998
30
0.040
 Why?
Models, Biological
1
2001
735
0.040
 Why?
Survival Rate
1
2020
945
0.030
 Why?
Adolescent
1
2008
6739
0.030
 Why?
Retrospective Studies
1
2008
6607
0.030
 Why?
Child
1
2008
7248
0.030
 Why?
CpG Islands
1
2015
121
0.030
 Why?
Disease Progression
1
2015
871
0.020
 Why?
RNA Interference
1
2011
181
0.020
 Why?
RNA, Small Interfering
1
2011
213
0.020
 Why?
Lymphocyte Subsets
1
2003
14
0.010
 Why?
Simian virus 40
1
2003
14
0.010
 Why?
Immunoglobulin Variable Region
1
2003
17
0.010
 Why?
Mutagenesis, Site-Directed
1
2003
95
0.010
 Why?
Sequence Deletion
1
2003
73
0.010
 Why?
Protein Structure, Tertiary
1
2003
242
0.010
 Why?
Recombinant Fusion Proteins
1
2003
177
0.010
 Why?
Down-Regulation
1
2003
346
0.010
 Why?
Up-Regulation
1
2003
454
0.010
 Why?
HIV Envelope Protein gp160
1
1999
2
0.010
 Why?
Radiation Chimera
1
1999
4
0.010
 Why?
beta 2-Microglobulin
1
1999
39
0.010
 Why?
Protein Engineering
1
1999
20
0.010
 Why?
Plants, Toxic
1
1998
10
0.010
 Why?
Enzyme Stability
1
1998
21
0.010
 Why?
Plants, Genetically Modified
1
1998
19
0.010
 Why?
Stem Cells
1
1999
177
0.010
 Why?
Hot Temperature
1
1998
214
0.010
 Why?
Signal Transduction
1
2003
1671
0.010
 Why?
Mice, Knockout
1
1999
879
0.010
 Why?
Mice, Inbred C57BL
1
1999
1884
0.010
 Why?
Muscle, Skeletal
1
1999
804
0.010
 Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (272) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department